Table:
begin	end	state
1	20	cytoplasmic
21	43	transmembrane
44	48	non-cytoplasmic
49	76	transmembrane
77	85	cytoplasmic
86	109	transmembrane
110	114	non-cytoplasmic
115	116	transmembrane
117	118	non-cytoplasmic
119	140	transmembrane
141	151	cytoplasmic
152	177	transmembrane
178	184	non-cytoplasmic
185	205	transmembrane
206	234	cytoplasmic
235	254	transmembrane
255	273	non-cytoplasmic
274	293	transmembrane
294	302	cytoplasmic
303	324	transmembrane
325	335	non-cytoplasmic
336	356	transmembrane
357	367	cytoplasmic
368	389	transmembrane
390	398	non-cytoplasmic
399	417	transmembrane
418	433	cytoplasmic

Input:
>RR42_RS07875
MSSSPSQQHGFRTVFRVVSGNFLEMYDFMVYGFYAAAIAKTFFPSGNEFASLMLSLATFG
AGFLMRPLGAIILGAYIDHHGRRKGLIMTLVLMALGTLLIACVPGYASIGVAAPLLVLAG
RLLQGFSAGVELGGVSVYLAEIAKPGKKGFYVAWQSASQQVAVIFAGLLGVVLHSMLSPE
EMGEWGWRIPFLIGCLIVPFLFLIRRSLEETEEFKTRKHRPSISEIYRSMMENWRIIVAG
CMMVVMTTVSFYMITAYTPTFGKTVLKLDDVDNLIVTMCVGLSNFIWLPLMGALSDRVGR
KPLLVIFTILTLLTAYPAVSWLVAEPSFGRLLMVELWLSFLYGSYNGAMVVTLTEVMPPA
VRTAGFSLAYSLATALFGGFTPAISTYLIHSTGNKAAPGLWLMFAAACGLIATLVIFRGG
RQHAYVEPAAKTA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server